ACS National Meeting Spring 2025 Symposia
Monday March 24: Advances and Perspectives of Cannabis Research in Medicinal Chemistry, Analysis and Bioanalysis Session 1
|
12:00 PM – 3:20 PM EDT Room: Digital Session (Digital Meeting)
|
Role of endocannabinoid and monoaminergic systems in modulating pain and comorbidities in osteoarthritis: a network approach
|
|
|
Chlorophyll derivatives in cannabis: More than just green color
|
||
|
Phytocannabinoids in Crohn’s disease, modulation of inflammatory signals in pre-clinical in vitro models
|
||
|
Cannabis, cannabinoids and cancer: a preclinical study
|
Federica Pellati, University of Modena and Reggio Emilia |
|
|
Time in cannabis storage: isolation of cannabinovarinic acid and 10a-D9- tetrahydrocannabivarin
|
Federica Pollastro, Universita degli Studi del Piemonte Orientale Amedeo Avogadro |
|
|
Fully-automated cannabinoid testing through advanced urine microsampling
|
Laura Mercolini, Alma Mater Studiorum – University of Bologna |
|
|
Concluding remarks
|
||
Tuesday March 25: Insights From FOIA Data on Cannabis Testing Across the U.S Session 2
|
11:05 – 11:55 AM EDT Room 29D (San Diego Convention Center)
|
Access to nationwide cannabis testing data and the path forward
|
Yasha Kahn, MCR Labs |
| 11:50 AM – 12:20 PM EDT |
Comprehensive multi-state analysis of cannabis testing with public data
|
|
| 12:20 PM – 12:50 PM EDT |
Regional (in)consistency and comparability of cannabis laboratory testing
|
|
| 12:50 PM – 1:05 PM EDT | BREAK | |
| 1:05 PM – 1:35 PM EDT |
Lab shopping and other fraudulent practices’ impact on U.S. states’ cannabis markets: insights from FOIA data
|
|
| 1:35 PM – 2:05 PM EDT |
Aspergillus testing trends of cannabis flower in the United States
|
Kyle Boyar, Bio-Rad Laboratories Inc |
| 2:35 PM – 2:55 PM EDT | Panel Discussion |
Tuesday March 25: Synthetic & Semi-Synthetic Cannabinoids Session 3
|
5:05 PM – 5:25 PM EDT
Room 29D (San Diego Convention Center) |
Cannabinoids decoded: Speaking the same language in a growing field
|
Christopher Hudalla, ProVerde Laboratories |
| 5:25 PM – 5:50 PM EDT |
Historical and contemporary perspectives on cannabinoids: Natural, synthetic, and designer variants for therapeutic application
|
|
| 5:50 PM – 6:15 PM EDT |
Delta-8-Tetrahydrocannabinol and the 2018 Farm Bill
|
Mahmoud Elsohly, Elsohly Labs Inc |
| 6:15 PM – 6:40 PM EDT |
DSI-GC-MS and Benchtop NMR: new tools for the analysis of designer cannabis products
|
|
| 6:40 PM – 6:55 PM EDT |
Intermission
|
|
| 6:55 PM – 7:20 PM EDT |
Chemical transformation of phytocannabinoids
|
|
| 7:20 PM – 7:45 PM EDT |
Modified Pickering catalysis: Green transfer hydrogenation of the trisubstituted olefin of tetrahydocannabinol
|
|
| 7:45 PM – 8:10 PM EDT |
Cannabis products and the potential impact on patients
|
|
Wednesday March 26: Advances and Perspectives of Cannabis Research in Medicinal Chemistry, Analysis and Bioanalysis
|
12:00 PM – 2:40 PM EDT Digital Session (Digital Meeting)
|
Targeted profiling for phytocannabinoids and synthetic contaminants in cannabis products
|
Michele Protti, Alma Mater Studiorum – University of Bologna |
|
Hemp biomass as a sustainable raw material for animal feed: preliminary insights and prospects
|
||
|
Development of a novel HPLC method with different detection systems to identify impurities in cannabidiol samples and determine its origin
|
||
|
Comparison of vaped and smoked cannabis: Analysis of emissions from dried cannabis via combustion of pre-rolled joints or dry-herb vaporization
|
||
|
Preclinical evidences of the effects of phytocannabinoids in murine glioblastoma in vitro models
|
||
|
Enzimatic promisquity: a biomimetic approach to synthesize rare cannabigerol-type Cannabinoids
|
||
|
Multi-layered approach to probe the biological space of cannabidiolic acid in glioblastoma cells
|
||
Additional Resources
Amber Wise, PhD
Programming Committee Chair
programming@cann-acs.org
Amber Wise has a PhD in Chemistry from UC-Berkeley and spent the early part of her career as an undergraduate chemistry lecturer and research professor for 7 years at universities in San Francisco, Bangladesh and Chicago. After transitioning out of academia in 2016, she was the Scientific Director at Avitas Agriculture in Washington and Oregon for two years, overseeing the cannabis extraction and refinement facilities and handling the data analysis, new product development and scientific growth of the company. She is currently the Science director at Medicine Creek Analytics, an ISO-17025 accredited cannabis testing lab outside Seattle. She serves on the Washington State Dept. of Ecology Cannabis Science Task Force Steering Committee and assists in organizing a Seattle-based cannabis science group, CANN-STEM.